Researchers often struggle to validate their cancer biomarker findings due to a lack of reproducible methods to measure predictive proteins. Now, investigators believe they've discovered a way to measure the entire human repertoire of proteins.
Scientists believe that for the first time, they have linked the gene CUX1 to the development of one in every 100 tumors in cancer patients.
Once a patient is treated for prostate cancer, close medical monitoring offers an imperfect way to catch potential recurrence or spread of the disease. Researchers believe they've found an easier way to get the job done: a biomarker for a cellular switch.
For any company entering the immunotherapy field, manufacturing and logistics are huge challenges. At newly formed Juno Therapeutics, they have a plan to overcome these obstacles--find a CEO who has done it before and back him with $120 million.
A negative test result for certain BRCA2 gene mutations--which increase susceptibility to tumor growth--may not be an accurate indicator of a woman's lower risk for breast cancer.
Researchers on the lookout for ways to help detect one of the world's deadliest cancers may have a new biomarker on their hands. In lung cancer patients, scientists have linked the presence in tumors of the protein C4d to a higher cancer mortality rate, a new study says.
The environment that exists inside a person's intestines may impact the effectiveness of cancer therapy, according to new research by investigators at the National Cancer Institute and France's Gustave Roussy Institute.
Investigators at the University of Toronto say that the S100A7 protein can be used to flag precancerous oral lesions, precursors to cancer of the mouth, which is a particularly serious threat in Asia.
Lately, there's been a lot of scrutiny surrounding preclinical research. Last year, a former researcher at Amgen ($AMGN) found that many basic cancer studies--published in leading science...
While some investigators are seeking better ways to treat pancreatic cancer, others have been tracking biomarkers that can offer a more accurate way to identify the lethal disease earlier on, so patients can be treated while there's a greater chance of fighting the disease.